[go: up one dir, main page]

ATE75395T1 - Linolensaeuren enthaltende pharmazeutische und diaet-zusammensetzungen zur behandlung von gutartiger prostatahypertrophie. - Google Patents

Linolensaeuren enthaltende pharmazeutische und diaet-zusammensetzungen zur behandlung von gutartiger prostatahypertrophie.

Info

Publication number
ATE75395T1
ATE75395T1 AT86301300T AT86301300T ATE75395T1 AT E75395 T1 ATE75395 T1 AT E75395T1 AT 86301300 T AT86301300 T AT 86301300T AT 86301300 T AT86301300 T AT 86301300T AT E75395 T1 ATE75395 T1 AT E75395T1
Authority
AT
Austria
Prior art keywords
treatment
pharmaceutical
compositions containing
benign prostate
prostate hypertrophy
Prior art date
Application number
AT86301300T
Other languages
English (en)
Inventor
David Frederick C O E Horrobin
Meadows Woodbridge
Original Assignee
Efamol Holdings
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Efamol Holdings filed Critical Efamol Holdings
Application granted granted Critical
Publication of ATE75395T1 publication Critical patent/ATE75395T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
AT86301300T 1985-03-08 1986-02-24 Linolensaeuren enthaltende pharmazeutische und diaet-zusammensetzungen zur behandlung von gutartiger prostatahypertrophie. ATE75395T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB858506027A GB8506027D0 (en) 1985-03-08 1985-03-08 Pharmaceutical & dietary compositions
EP86301300A EP0201159B1 (de) 1985-03-08 1986-02-24 Linolensäuren enthaltende pharmazeutische und Diät-Zusammensetzungen zur Behandlung von gutartiger Prostatahypertrophie

Publications (1)

Publication Number Publication Date
ATE75395T1 true ATE75395T1 (de) 1992-05-15

Family

ID=10575663

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86301300T ATE75395T1 (de) 1985-03-08 1986-02-24 Linolensaeuren enthaltende pharmazeutische und diaet-zusammensetzungen zur behandlung von gutartiger prostatahypertrophie.

Country Status (11)

Country Link
US (1) US4898885A (de)
EP (1) EP0201159B1 (de)
JP (1) JPH0717515B2 (de)
AT (1) ATE75395T1 (de)
AU (1) AU581295B2 (de)
CA (1) CA1268122A (de)
DE (1) DE3685052D1 (de)
GB (1) GB8506027D0 (de)
HK (1) HK8294A (de)
IE (1) IE58891B1 (de)
ZA (1) ZA861459B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2716739B2 (ja) * 1988-07-26 1998-02-18 インデナ エス．ピー．エイ 血管運動作用を有する化粧用組成物
EP0437694B1 (de) * 1990-01-16 1993-06-16 Boots Pharma GmbH Verwendung einer Hydroxyoctadecadiensäure, deren zur Ketoform oxidierte Säure sowie deren Derivate zur Therapie östrogenabhängiger Krankheiten, sowie pharmazeutische Zusammensetzungen, die diese enthalten
GB9012651D0 (en) * 1990-06-06 1990-07-25 Efamol Holdings Essential fatty acid treatment
WO1994015464A1 (en) * 1993-01-15 1994-07-21 Abbott Laboratories Structured lipids
AU711482B2 (en) * 1994-06-28 1999-10-14 Scotia Holdings Plc Compositions for treatment of diabetic complications
DE19825591A1 (de) * 1998-06-09 1999-12-23 Jenapharm Gmbh Pharmazeutische Kombinationen zum Ausgleich eines Testosteron-Defizits beim Mann mit gleichzeitigem Schutz der Prostata
DE10006836B4 (de) * 2000-04-18 2005-03-24 Bitec Gmbh Verwendung von Omega-3-Fettsäuren und/oder Verbindungen von Omega-3-Fettsäuren
CA2436650A1 (en) * 2003-08-06 2005-02-06 Naturia Inc. Conjugated linolenic acid (clnatm) compositions: synthesis, purification and uses
IT1391663B1 (it) 2008-11-10 2012-01-17 Giuliani Spa Uso di composti atti ad inibire l' attivita' dell'enzima 5alfa-reduttasi e composizioni farmaceutiche e cosmetiche che li contengono
GB0907413D0 (en) 2009-04-29 2009-06-10 Equateq Ltd Novel methods
ES2385240B1 (es) 2010-07-26 2013-09-23 Gp-Pharm, S.A. Cápsulas de principios activos farmacéuticos y ácidos grasos poliinsaturados para el tratamiento de enfermedades de la próstata.
US8293790B2 (en) 2011-10-19 2012-10-23 Dignity Sciences Limited Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof
MA52644A (fr) 2014-06-04 2021-03-24 Ds Biopharma Ltd Compositions pharmaceutiques comprenant de l'acide dgla et leur utilisation
US20210315851A1 (en) 2020-04-03 2021-10-14 Afimmune Limited Compositions comprising 15-hepe and methods of treating or preventing hematologic disorders, and/or related diseases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4273763A (en) * 1978-01-23 1981-06-16 Efamol Limited Pharmaceutical and dietary compositions
EP0004770B1 (de) * 1978-04-11 1984-06-13 Efamol Limited Pharmazeutische und diätetische Zusammensetzung mit Gehalt an Gamma-Linolensäuren
IE49783B1 (en) * 1979-05-18 1985-12-11 Efamol Ltd Pharmaceutical and dietary composition comprising epsilon-linolenic acids
IE53332B1 (en) * 1980-03-14 1988-10-26 Efamol Ltd Pharmaceutical compositions
US4386072A (en) * 1981-06-26 1983-05-31 Horrobin David F Treatment of disorders of inflammation and immunity and disorders associated with smooth muscle spasm and compositions therefor
ATE11014T1 (de) * 1981-07-14 1985-01-15 Efamol Limited Pharmazeutische und diaetetische zusammensetzung zur erhoehung der serie-l-pg-produktion.
GB8302708D0 (en) * 1983-02-01 1983-03-02 Efamol Ltd Pharmaceutical and dietary composition

Also Published As

Publication number Publication date
HK8294A (en) 1994-02-04
EP0201159A3 (en) 1989-08-09
JPS61207330A (ja) 1986-09-13
IE58891B1 (en) 1993-12-01
EP0201159B1 (de) 1992-04-29
IE860516L (en) 1986-09-08
US4898885A (en) 1990-02-06
ZA861459B (en) 1986-11-26
AU5428586A (en) 1986-09-11
GB8506027D0 (en) 1985-04-11
CA1268122A (en) 1990-04-24
AU581295B2 (en) 1989-02-16
DE3685052D1 (de) 1992-06-04
EP0201159A2 (de) 1986-11-12
JPH0717515B2 (ja) 1995-03-01

Similar Documents

Publication Publication Date Title
ATE75395T1 (de) Linolensaeuren enthaltende pharmazeutische und diaet-zusammensetzungen zur behandlung von gutartiger prostatahypertrophie.
MY101791A (en) New benzimidazole derivatives
NO940277L (no) Triglycerider og blandinger av slike
IS1904B (is) Hliðstæðar aðferðir við framleiðslu á nýjum (R)-5-karbamóýl-8-flúor-3-N,N-tvíútskiptum-amínó-3,4-díhýdró-2H-1-bensópýrönum
PL268927A1 (en) Method of obtaining novel derivatives of benzimidazole
ES8402560A1 (es) Procedimiento para la obtencion de nuevos derivados de omega-ciano-1,omega-difenil-aza-alcano.
ATE44235T1 (de) Verwendung von kupfer und fettsaeulen.
GR3025742T3 (en) New pyrazine derivatives, their preparation and their use.
AU554413B2 (en) Linoleic acid and essential fatty acid compositions as
IL85189A (en) Beta-alkyl substituted melatonins,their preparation and pharmaceutical compositions containing them
ATE52261T1 (de) Oxa-fenchole und oxa-fenchylamine, geeignet zur herstellung hochwirksamer suessstoffe.
ATE2746T1 (de) Piperidinderivate von 4,5-dialkyl-3-hydroxypyrrol-2-carbons[ureestern, ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
GR3002215T3 (en) Calcium lactate-glycerine additive, process for its preparation and its use
ATE4808T1 (de) Piperidinderivate von 3-hydroxy-thiophen-2carbons[ureestern,ihre herstellung und diese enthaltende pharmazeutische zubereitungen.
JPS5217482A (en) Preparation of quinazolinone derivatives
JPS52130905A (en) Medicinal composition
ES8608861A1 (es) Procedimiento para la preparacion de composiciones farmaceuticas hidrosolubles a base de sales de fosfomicina.
JPS5251362A (en) Preparation of optically active pyrrolidine derivatives
GB2006207A (en) N- epsilon -Trimethyl-L-lysine salts
ES8401483A1 (es) Procedimiento para preparar nuevas furobenzazepinas.
JPS5285200A (en) Preparation of amino acid
ATE96150T1 (de) Thioester und dessen verwendung zur herstellung von pharmazeutischen zusammensetzungen zur behandlung von ischaemie und von reperfusionsyndromen.
AU102478S (en) Flag
BG52067B2 (en) Antihypoxic and brain-protection antidote composition